| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 3210 | 2019 |
| Treating rheumatoid arthritis to target: recommendations of an international task force JS Smolen, D Aletaha, JWJ Bijlsma, FC Breedveld, D Boumpas, ... Annals of the rheumatic diseases 69 (4), 631-637, 2010 | 2966 | 2010 |
| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 1999 | 2019 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1270 | 2012 |
| Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates DT Boumpas, GP Chrousos, RL Wilder, TR Cupps, JE Balow Annals of internal medicine 119 (12), 1198-1208, 1993 | 1086 | 1993 |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including … GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ... Annals of the rheumatic diseases 67 (2), 195-205, 2008 | 1055 | 2008 |
| Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis DT Boumpas, HA Austin III, JE Balow, EM Vaughan, CH Yarboro, ... The lancet 340 (8822), 741-745, 1992 | 1052 | 1992 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 918 | 2017 |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for … GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ... Annals of the rheumatic diseases 69 (12), 2074-2082, 2010 | 913 | 2010 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 855 | 2014 |
| Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis: a randomized, controlled trial MF Gourley, HA Austin III, D Scott, CH Yarboro, EM Vaughan, J Muir, ... Annals of internal medicine 125 (7), 549-557, 1996 | 821 | 1996 |
| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 799 | 2020 |
| A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis DT Boumpas, R Furie, S Manzi, GG Illei, DJ Wallace, JE Balow, ... Arthritis & Rheumatism 48 (3), 719-727, 2003 | 736 | 2003 |
| Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis GG Illei, HA Austin III, M Crane, L Collins, MF Gourley, CH Yarboro, ... Annals of internal medicine 135 (4), 248-257, 2001 | 709 | 2001 |
| Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research … K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ... Annals of the rheumatic diseases 68 (7), 1086-1093, 2009 | 675 | 2009 |
| Update οn the diagnosis and management of systemic lupus erythematosus A Fanouriakis, N Tziolos, G Bertsias, DT Boumpas Annals of the rheumatic diseases 80 (1), 14-25, 2021 | 651 | 2021 |
| Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy DT Boumpas, HA Austin, EM Vaughan, CH Yarboro, JH Klippel, JE Balow Annals of internal medicine 119 (5), 366-369, 1993 | 640 | 1993 |
| European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ... Annals of the rheumatic diseases 71 (1), 4-12, 2012 | 612 | 2012 |
| EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases JN Hoes, JWG Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, ... Annals of the rheumatic diseases 66 (12), 1560-1567, 2007 | 569 | 2007 |
| Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data HA Austin III, DT Boumpas, EM Vaughan, JE Balow Kidney international 45 (2), 544-550, 1994 | 520 | 1994 |
